|
ES2278390T3
(es)
*
|
1996-05-23 |
2007-08-01 |
The Scripps Research Institute |
Sistema de presentacion de antigenos de clase ii de cmh y procedimientos de activacion de linfocitos t cd4+.
|
|
US6291430B1
(en)
*
|
1997-09-12 |
2001-09-18 |
Ludwig Institute For Cancer Research |
Mage-3 peptides presented by HLA class II molecules
|
|
AU765085B2
(en)
|
1998-05-11 |
2003-09-11 |
Miltenyi Biotec Gmbh |
Method of direct selection of antigen-specific T cells
|
|
US6230662B1
(en)
|
1998-06-22 |
2001-05-15 |
Theresa Miale |
Animal lift and transport apparatus and method for using the same
|
|
EP1104456A1
(en)
*
|
1998-08-10 |
2001-06-06 |
Chiron Corporation |
Engineered antigen-presenting cells expressing an array of antigens and uses thereof
|
|
US7807377B2
(en)
|
1998-10-20 |
2010-10-05 |
Salvatore Albani |
Method of isolating antigen-specific T cells employing artificial antigen presenting cells
|
|
ATE459339T1
(de)
*
|
1998-10-20 |
2010-03-15 |
Androclus Technologies S R L I |
Künstliche antigen-spezifischen zellen und zugehörige verfahren
|
|
US6225443B1
(en)
*
|
1999-05-19 |
2001-05-01 |
Wisconsin Alumni Research Foundation |
Cytotoxic T lymphocyte epitopes of the major outer membrane protein of chlamydia trachomatis
|
|
US7521202B2
(en)
|
1999-12-17 |
2009-04-21 |
The Board Of Regents Of The University Of Oklahoma |
Method and apparatus for the production of soluble MHC antigens and uses thereof
|
|
DE10009341A1
(de)
*
|
2000-02-22 |
2001-09-06 |
Florian Kern |
Verfahren zur antigen-spezifischen Stimulation von T-Lymphozyten
|
|
US7541184B2
(en)
|
2000-02-24 |
2009-06-02 |
Invitrogen Corporation |
Activation and expansion of cells
|
|
US7572631B2
(en)
|
2000-02-24 |
2009-08-11 |
Invitrogen Corporation |
Activation and expansion of T cells
|
|
WO2001080833A1
(en)
*
|
2000-04-20 |
2001-11-01 |
Salvatore Albani |
Methods for isolation, quantification, characterization and modulation of antigen-specific t cells
|
|
CA2433194C
(en)
|
2000-10-10 |
2012-04-03 |
The Board Of Regents Of The University Of Oklahoma |
Comparative ligand mapping from mhc positive cells
|
|
US20070026433A1
(en)
|
2001-03-09 |
2007-02-01 |
Hildebrand William H |
Epitope testing using soluble HLA
|
|
WO2002056908A2
(en)
*
|
2001-01-16 |
2002-07-25 |
Hildebrand William H |
Artificial antigen-presenting cells
|
|
WO2002079396A2
(en)
*
|
2001-02-13 |
2002-10-10 |
Mosca Joseph D |
Biological carriers for induction of immune responses
|
|
US20040071671A1
(en)
*
|
2001-02-20 |
2004-04-15 |
Leturcq Didier J. |
Cell therapy method for the treatment of tumors
|
|
HUP0402656A3
(en)
*
|
2001-02-20 |
2012-03-28 |
Ortho Mcneil Pharm Inc |
A cell therapy method for the treatment of tumors
|
|
FR2824567B1
(fr)
*
|
2001-05-11 |
2003-08-08 |
Inst Nat Sante Rech Med |
Procede d'obtention de lymphocytes tr1 regulateurs specifiques d'antigene
|
|
US7745140B2
(en)
*
|
2002-01-03 |
2010-06-29 |
The Trustees Of The University Of Pennsylvania |
Activation and expansion of T-cells using an engineered multivalent signaling platform as a research tool
|
|
US7638325B2
(en)
*
|
2002-01-03 |
2009-12-29 |
The Trustees Of The University Of Pennsylvania |
Activation and expansion of T-cells using an engineered multivalent signaling platform
|
|
US7638326B2
(en)
|
2002-01-03 |
2009-12-29 |
The Trustees Of The University Of Pennsylvania |
Activation and expansion of T-cells using an engineered multivalent signaling platform
|
|
EP1408106B1
(en)
*
|
2002-10-11 |
2007-02-14 |
Sentoclone Therapeutics AB |
Cancer immuno-therapy
|
|
US20040072262A1
(en)
*
|
2002-10-11 |
2004-04-15 |
Montero-Julian Felix A. |
Methods and systems for detecting MHC class I binding peptides
|
|
US7435592B2
(en)
|
2003-05-13 |
2008-10-14 |
Immunovative Therapies, Ltd. |
Compositions for allogeneic cell therapy
|
|
EP1692504A4
(en)
*
|
2003-11-03 |
2007-06-27 |
Beckman Coulter Inc |
METHODS BASED ON DETECTION SOLUTIONS OF PEPTIDES FIXING AT THE MHC
|
|
DK2573166T3
(da)
|
2004-02-26 |
2016-07-04 |
Immunovative Therapies Ltd |
Fremgangsmåder til fremstilling af T-celler til celleterapi
|
|
US7592431B2
(en)
|
2004-02-26 |
2009-09-22 |
Immunovative Therapies, Ltd. |
Biodegradable T-cell Activation device
|
|
JP2007536522A
(ja)
*
|
2004-05-07 |
2007-12-13 |
ベックマン コールター インコーポレーティッド |
Ｃｔｌの媒介による抗原提示細胞の溶解を検出するためのｍｈｃ架橋系
|
|
WO2005118788A2
(en)
|
2004-05-27 |
2005-12-15 |
The Trustees Of The University Of Pennsylvania |
Novel artificial antigen presenting cells and uses therefor
|
|
WO2006009838A2
(en)
*
|
2004-06-17 |
2006-01-26 |
Beckman Coulter, Inc. |
Mycobacterium tuberculosis epitopes and methods of use thereof
|
|
EP1712615A1
(en)
*
|
2005-04-15 |
2006-10-18 |
Txcell |
In vitro production of a cell population using feeder cells
|
|
CN104436190A
(zh)
|
2005-06-08 |
2015-03-25 |
达纳-法伯癌症研究院公司 |
通过抑制程序性细胞死亡1(pd-1)途经治疗持续性感染和癌症的方法及组合物
|
|
WO2006138449A2
(en)
*
|
2005-06-16 |
2006-12-28 |
The Wistar Institute |
Method for identifying a mhc class ii-dependent tumor-associated t helper cell antigen
|
|
WO2007071388A1
(en)
|
2005-12-21 |
2007-06-28 |
Sentoclone Ab |
Improved method for expansion of tumour-reactive t-lymphocytes for immunotherapy of patients with cancer
|
|
JP5205275B2
(ja)
|
2005-12-21 |
2013-06-05 |
セントクローネ インターナショナル エービー |
散在性ガンの治療法
|
|
US8101173B2
(en)
|
2005-12-21 |
2012-01-24 |
Sentoclone International Ab |
Method for treating urinary bladder cancer
|
|
WO2007071390A1
(en)
|
2005-12-21 |
2007-06-28 |
Sentoclone Ab |
Method for treating malignant melanoma
|
|
MX2008011302A
(es)
*
|
2006-03-01 |
2008-11-04 |
Janssen Pharmaceutica Nv |
Tratamiento de cancer que combina agente de linfodeplecion con linfocitos t citotoxicos y citocinas.
|
|
EP2079830B1
(en)
*
|
2006-10-04 |
2016-08-17 |
Janssen Pharmaceutica NV |
Preparation of inactivated artificial antigen presenting cells and their use in cell therapies
|
|
CA2673870A1
(en)
*
|
2006-12-27 |
2008-07-10 |
Emory University |
Compositions and methods for the treatment of infections and tumors
|
|
US20120034156A1
(en)
*
|
2010-08-03 |
2012-02-09 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Artificial cells
|
|
EP2370593B1
(en)
|
2008-11-28 |
2016-03-30 |
Emory University |
Methods for determining the efficacy of pd-1 antagonists
|
|
US8075895B2
(en)
*
|
2009-09-22 |
2011-12-13 |
Janssen Pharmaceutica N.V. |
Identification of antigenic peptides from multiple myeloma cells
|
|
EP2404618A1
(en)
|
2010-07-07 |
2012-01-11 |
Stichting Katholieke Universiteit meer in het bijzonder Radboud Universiteit Nijmegen |
Immunomodulatory protein constructs with a helical polymeric backbone.
|
|
WO2012017678A1
(ja)
*
|
2010-08-06 |
2012-02-09 |
株式会社ケーナインラボ |
免疫機能の強化剤
|
|
PH12013502252B1
(en)
|
2011-05-03 |
2018-09-21 |
Immunovative Therapies Ltd |
Induction of il-12 using immunotherapy
|
|
PH12013502253A1
(en)
|
2011-05-03 |
2019-11-29 |
Immunovative Therapies Ltd |
Methods for handling biological drugs containing living cells
|
|
EP2841563B1
(en)
|
2012-04-24 |
2019-06-12 |
Dan S. Kaufman |
Method for developing natural killer cells from stem cells
|
|
EP2997134B1
(en)
|
2013-05-14 |
2020-06-24 |
Board of Regents, The University of Texas System |
Human application of engineered chimeric antigen receptor (car) t-cells
|
|
WO2015095167A2
(en)
|
2013-12-16 |
2015-06-25 |
Chatterjee Deb K |
Cancer immunotherapy by delivering class ii mhc antigens using a vlp-replicon
|
|
CN106414748B
(zh)
|
2014-02-14 |
2021-05-28 |
得克萨斯州大学系统董事会 |
嵌合抗原受体及制备方法
|
|
WO2015148960A1
(en)
|
2014-03-28 |
2015-10-01 |
The Board Of Regents Of The University Of Oklahoma |
Compositions comprising soluble hla/m. tuberculosis-specific ligand complexes and methods of production and use thereof
|
|
CN106459924A
(zh)
|
2014-04-23 |
2017-02-22 |
得克萨斯州大学系统董事会 |
用于疗法中的嵌合抗原受体(car)及其制备方法
|
|
CA2945393C
(en)
|
2014-04-24 |
2021-03-23 |
Board Of Regents, The University Of Texas System |
Application of induced pluripotent stem cells to generate adoptive cell therapy products
|
|
US20170333480A1
(en)
|
2014-11-05 |
2017-11-23 |
Board Of Regents, The University Of Texas System |
Gene modified immune effector cells and engineered cells for expansion of immune effector cells
|
|
US10570186B2
(en)
|
2014-11-05 |
2020-02-25 |
Board Of Regents, The University Of Texas System |
Chimeric antigen receptors (CAR) to selectively target protein complexes
|
|
FR3031519B1
(fr)
|
2015-01-14 |
2016-12-30 |
Arkema France |
Composition a base de terpolymere electroactif
|
|
KR102668219B1
(ko)
*
|
2015-03-16 |
2024-05-28 |
막스-델부뤽-센트럼 퓌어 몰레쿨라레 메디친 인 데어 헬름홀츠-게마인샤프트 |
Mhc 세포 라이브러리를 이용하여 신규한 면역원성 t 세포 에피토프를 검출하고 신규한 항원-특이적 t 세포 수용체를 단리하는 방법
|
|
EP3368075B1
(en)
|
2015-10-27 |
2020-01-29 |
Board of Regents, The University of Texas System |
Chimeric antigen receptor molecules and uses thereof
|
|
JP7591342B2
(ja)
|
2016-06-08 |
2024-11-28 |
プレシゲン，インコーポレイテッド |
Ｃｄ３３特異的キメラ抗原受容体
|
|
MA45784A
(fr)
|
2016-07-29 |
2019-06-05 |
Juno Therapeutics Inc |
Anticorps anti-idiotypes dirigés contre anti-cd19 anticorps
|
|
EP3538112B1
(en)
|
2016-11-09 |
2026-02-25 |
Musc Foundation for Research Development |
Cd38-nad+ regulated metabolic axis in anti-tumor immunotherapy
|
|
CA3049652A1
(en)
|
2017-01-10 |
2018-07-19 |
Intrexon Corporation |
Modulating expression of polypeptides via new gene switch expression systems
|
|
US11285196B2
(en)
|
2017-03-13 |
2022-03-29 |
Eslam Abbas Baseuny |
Multivalent biologic constructs for inducing a therapeutic modulation of cellular response and uses thereof
|
|
ES2912383T3
(es)
|
2017-04-18 |
2022-05-25 |
Fujifilm Cellular Dynamics Inc |
Células efectoras inmunitarias específicas de antígeno
|
|
CN110997920A
(zh)
|
2017-06-07 |
2020-04-10 |
英特拉克森公司 |
新型细胞标签的表达
|
|
KR102823603B1
(ko)
|
2017-10-12 |
2025-06-23 |
더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 |
면역요법을 위한 t 세포 수용체
|
|
JP7273421B2
(ja)
|
2018-02-21 |
2023-05-15 |
ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム |
ナチュラルキラー細胞の活性化および拡大のための方法ならびにその使用
|
|
BR112021010297A2
(pt)
|
2018-11-28 |
2021-08-24 |
Board Of Regents, The University Of Texas System |
Edição de genomas multiplexadores de células imunes para aumentar a funcionalidade e resistência ao ambiente supressivo
|
|
WO2020112493A1
(en)
|
2018-11-29 |
2020-06-04 |
Board Of Regents, The University Of Texas System |
Methods for ex vivo expansion of natural killer cells and use thereof
|
|
CN120605327A
(zh)
|
2019-11-06 |
2025-09-09 |
贝勒医学院 |
用于产生细胞毒性效应子记忆t细胞以用于癌症的t细胞治疗的方法
|
|
US20230079539A1
(en)
|
2020-02-10 |
2023-03-16 |
Board Of Regents, The University Of Texas System |
Methods for rapid cloning and expression of hla class i cells
|
|
CN115715295A
(zh)
|
2020-05-27 |
2023-02-24 |
安逊生物科学股份有限公司 |
将car t细胞重新定向到感兴趣的抗原的衔接分子
|
|
WO2022140759A2
(en)
|
2020-12-23 |
2022-06-30 |
Janssen Biotech, Inc. |
Neoantigen peptide mimics
|
|
JP2025515324A
(ja)
|
2022-04-28 |
2025-05-14 |
エムユーエスシー ファウンデーション フォー リサーチ ディベロップメント |
がんを処置するためのキメラ抗原受容体改変調節性ｔ細胞
|